Related Experiment Videos
Respiratory diseases and high altitude
Annalisa Cogo1, Rainald Fischer, Robert Schoene
1Department of Clinical & Experimental Medicine, Section Respiratory Diseases, University of Ferrara, Università via Savonarola 9, 44100 Ferrara, Italy. annalisa.cogo@unife.it
High Altitude Medicine & Biology
|January 27, 2005
Summary
This review explores how altitude exposure impacts obstructive, restrictive, and pulmonary vascular diseases. It offers clinicians guidance for managing patients with these conditions at high altitudes.
Area of Science:
- Pulmonary Medicine
- Environmental Health
- Altitude Physiology
Background:
- Preexisting pulmonary diseases pose challenges during altitude exposure.
- Conditions include obstructive (asthma, COPD), restrictive (IPF), and pulmonary vascular diseases.
- Hypobaric hypoxia significantly affects respiratory function.
Purpose of the Study:
- To review the impact of altitude on various pulmonary diseases.
- To provide clinicians with tools for optimizing patient care at altitude.
- To enhance the quality of life for patients with pulmonary conditions exposed to high altitudes.
Main Methods:
- Literature review of pathophysiologies and clinical effects.
- Analysis of hypobaric hypoxia's influence on specific lung diseases.
- Examination of assessment techniques and therapeutic interventions.
Main Results:
- Detailed review of how asthma, COPD, IPF, and pulmonary vascular diseases are affected by altitude.
- Understanding of pathophysiological changes induced by hypobaric hypoxia.
- Discussion of appropriate patient assessment strategies.
Conclusions:
- Altitude exposure necessitates careful management of preexisting pulmonary diseases.
- Clinicians can optimize patient outcomes through informed assessment and tailored interventions.
- Supplemental oxygen and other therapies are crucial for managing respiratory compromise at high altitudes.